Nutraceutical News and Research RSS Feed - Nutraceutical News and Research

Nutraceutical, a portmanteau the words “nutrition” and “pharmaceutical”, is a food or food product that provides health and medical benefits, including the prevention and treatment of disease.
Q'SAI announces formation of new U.S. subsidiary

Q'SAI announces formation of new U.S. subsidiary

Celebrating 50 years serving the healthy lifestyles of the Japanese, Q'SAI Co., Ltd., announces the formation of Q'SAI USA Inc., a new United States wholly owned subsidiary that will soon introduce American versions of health products that have become staples in Japan. [More]
ISG Health creates new algae-based nutraceutical products

ISG Health creates new algae-based nutraceutical products

International Sustainability Group, Inc. an innovative green technology company is pleased to announce that its wholly owned subsidiary ISG Health created its new algae based product line, being branded under the name AlgaeUP. [More]
Daily use of Pycnogenol may help improve overall cognitive function

Daily use of Pycnogenol may help improve overall cognitive function

New research delivers exciting news for those seeking natural ways to boost memory and mental performance. A study recently published in the Journal of Neurosurgical Sciences shows daily use of Pycnogenol (pic-noj-en-all), a natural plant extract from French maritime pine tree bark, may help improve attention span, memory, decision-making – including executive-level performance – and overall cognitive function. [More]

Healthplex & Nutraceutical China 2015 to be held in Shanghai, China

From 24-26 June 2015, Healthplex & Nutraceutical China (HNC) will return to Shanghai, China, to serve the Asian health industry. This year, the event will take place on a larger scale, with more exhibitors and business opportunities for those in attendance. [More]

New trial shows efficacy of PrimiCell product on muscle repair

BioAdaptives, Inc. announced results of the recently completed in vivo trial showing the efficacy of its PrimiCell product on muscle repair. [More]
Otsuka Pharmaceutical to acquire Avanir Pharmaceuticals for $3.5B

Otsuka Pharmaceutical to acquire Avanir Pharmaceuticals for $3.5B

Avanir Pharmaceuticals, Inc. today announced that it has entered into a definitive agreement with Otsuka Pharmaceutical Co., Ltd. pursuant to which Otsuka will acquire Avanir for $17.00 per share in cash. [More]
Health benefits of modified formulation of curcumin supplements

Health benefits of modified formulation of curcumin supplements

The health benefits of over-the-counter curcumin supplements might not get past your gut, but new research shows that a modified formulation of the spice releases its anti-inflammatory goodness throughout the body. [More]
DSM Venturing invests in ZeaVision Holdings

DSM Venturing invests in ZeaVision Holdings

ZeaVision Holdings, Inc., maker of the EyePromise® brand of doctor-recommended nutraceuticals, has received an equity investment from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company. [More]

Fi Asia-China 2014 held in Shanghai proved to be a great success

China's leading nutritional ingredients event, Food ingredients (Fi) Asia China, Health ingredients (Hi) and Natural ingredients (Ni), took place this June 26-28 in Shanghai, China and was a great success. [More]
Encapsula releases 2 new liposome based products

Encapsula releases 2 new liposome based products

Encapsula NanoSciences announces the release of two new liposome ­based products; Curcusome® and Taurosome™. Curcusome® or liposomal curcumin is a nutraceutical supplement that comes innovatively packaged in a powder ­release cap for consumer ease. [More]
GrowBLOX enters Florida Medical Marijuana Market through new subsidiary, GB Sciences

GrowBLOX enters Florida Medical Marijuana Market through new subsidiary, GB Sciences

GrowBLOX Sciences, Inc. a medical marijuana research and development company, is pleased to announce it has entered the Florida Medical Marijuana Market through its new subsidiary, GB Sciences Florida, LLC. With nearly 20 million residents, Florida is poised to be the biggest medical marijuana market outside of California. [More]
Kainos Capital announces acquisition of Unilever's Slim-Fast brand

Kainos Capital announces acquisition of Unilever's Slim-Fast brand

Kainos Capital, a firm specializing in acquiring and managing food and consumer brands, today announced that it has acquired the Slim-Fast brand from Unilever. Unilever will retain a minority stake in the business. Terms of the transaction were not disclosed. [More]
Ophthalmologist recommends alternative therapy for Graves' eye disease

Ophthalmologist recommends alternative therapy for Graves' eye disease

Don Parker was facing a second surgery to treat the bulging eyes and double vision he was experiencing due to Graves' eye disease. [More]

NTRR’s subsidiary Diamond Anvil Designs to release cutting-edge vaporizer pen next month

Neutra Corp., a provider of all-natural wellness solutions, announced today that its wholly owned subsidiary, Diamond Anvil Designs, is preparing to release its cutting-edge new vaporizer pen next month. [More]
Kush Creams to manufacture and distribute medical marijuana product, 5 Hour High

Kush Creams to manufacture and distribute medical marijuana product, 5 Hour High

Alternaturals, Inc., Symbol (OTCPink:ANAS) today announced that it has chosen Kush Creams, a Washington based, medical marijuana grower and distributor with award winning strains and products, to manufacture and distribute its long awaited medical marijuana product, 5 Hour High©. [More]
New book documents groundbreaking studies on modified citrus pectin

New book documents groundbreaking studies on modified citrus pectin

One of the nation's leading writers on the use of naturopathic medicine has released a new book documenting groundbreaking studies on modified citrus pectin (MCP) and its application for addressing serious health issues like cancer, heart disease, chronic inflammation and fibrosis. [More]

GrowBLOX Sciences’ patent-pending technology for medical-grade cannabis comes off production line

GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that the first of its patent pending proprietary agricultural indoor growing system for medical-grade cannabis has come off the production line. [More]

GrowBLOX Sciences relocates corporate headquarters to Las Vegas, Nevada

GrowBLOX Sciences, Inc. a biotechnology and research company, announced today that The Company has relocated its corporate headquarters to Las Vegas, Nevada and has centralized its CFO and team in the heart of Clark County in anticipation of its Nevada project. [More]
Study identifies role of additive monosodium glutamate in obesity and liver disease

Study identifies role of additive monosodium glutamate in obesity and liver disease

The commonly used food additive monosodium glutamate (MSG) has been linked to obesity and disorders associated with the metabolic syndrome including progressive liver disease. [More]

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. [More]